RxDoctor Payments Data

Johnathan Spitnale, DO

Family Medicine · Defiance, OHNPI 1285197046

Payments from drug & device makers

$994in general payments, 2019–2025

Across 60 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$147
  • Novo Nordisk$125
  • Otsuka America Pharmaceutical, Inc.$75
  • Pfizer$73
  • Exact Sciences$60
  • Bayer$53
  • plus $461 from 15 others

What the payments were for

  • Food & beverage$994100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$994 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$38,480
Medicare patients
213
Services billed
493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin38$52,522
MounjaroTirzepatide23$24,034
EliquisApixaban17$20,369
OzempicSemaglutide12$18,981
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$16,873
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$15,089
LinzessLinaclotide21$12,823
MyrbetriqMirabegron13$9,812
BelsomraSuvorexant15$6,297
Pregabalin33$2,776
Varenicline Tartrate15$1,789
Atorvastatin Calcium141$1,695
Albuterol Sulfate HfaAlbuterol Sulfate64$1,625
Potassium Chloride59$1,453
Celecoxib16$1,339

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$18$52,52238 claims
Lilly USA, LLCMounjaro$49$24,03423 claims
PfizerEliquis$73$20,36917 claims
Novo NordiskOzempic$125$18,98112 claims
GSKTrelegy Ellipta$49$15,08922 claims
AbbVieLinzess$147$12,82321 claims
Astellas Pharma US IncMyrbetriq$15$9,81213 claims
MerckBelsomra$24$6,29715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Defiance

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →